| Shreekrishna Biotech Ltd | Industry : (Finance) | |
|---|---|---|
|
BSE Code : 505592 |
NSE Symbol : - |
P/E(TTM) : - |
|
ISIN Demat : INE571N01015 |
Div & Yield% : - |
EPS(TTM) : - |
|
Book Value(₹) : 10.35 |
Market Cap(₹Cr) : 139.30 |
Face Value(₹) : 10.00 |
| Particulars | Mar '13 | Mar '12 | Mar '11 | Mar '00 | Mar '99 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Operating Income | - | - | 0.02 | 0.02 | - |
| Other Income | 0.03 | 0.02 | - | - | - |
| Total Income | 0.03 | 0.02 | 0.02 | 0.02 | - |
| EXPENDITURE : | |||||
| Operating & Administration Expenses | - | - | - | - | 0.01 |
| Miscellaneous Expenses | 0.02 | 0.02 | 0.02 | - | - |
| Interest | - | - | - | - | - |
| Less: Pre-operative Expenses Capitalised | - | - | - | - | - |
| Employee Expense | - | - | - | - | - |
| Total Expenditure | 0.02 | 0.02 | 0.02 | - | 0.01 |
| Gross Profit | 0.01 | 0.01 | - | 0.02 | -0.01 |
| Depreciation | - | - | - | - | - |
| Profit Before Tax | 0.01 | 0.01 | - | 0.02 | -0.01 |
| Current Tax | - | - | - | 0.01 | - |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | - | - | - | - | - |
| Reported Net Profit | - | - | - | 0.01 | -0.01 |
| Extraordinary Items | - | - | - | - | - |
| Adjusted Net Profit | - | - | - | 0.01 | -0.01 |
| Adjustment below net profit | - | - | - | - | - |
| Profit/Loss Balance brought forward | 0.08 | 0.08 | 0.08 | 0.10 | 0.11 |
| Appropriations | - | - | - | - | - |
| P & L Balance carried down | 0.08 | 0.08 | 0.08 | 0.11 | 0.10 |
| Dividend | - | - | - | - | - |
| Preference Share Dividend | - | - | - | - | - |
| Equity Dividend Rate (%) | - | - | - | - | - |
| Dividend Per Share(Rs) | - | - | - | - | - |
| Earnings Per Share-Unit Curr | 0.02 | 0.02 | - | 0.40 | - |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value-Unit Curr | 12.13 | 12.11 | 12.11 | 14.40 | 14.00 |
| Book Value(Adj)-Unit Curr | - | - | - | - | - |